Anlon Healthcare (NSE:AHCL) Current Accrued Expense: ₹0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:AHCL Anlon Healthcare Ltd NSE:AHCL
21 GF Score
Price ₹20.04
! 6 Warning Signs
View Full Analysis

What is Anlon Healthcare Current Accrued Expense?

Anlon Healthcare NSE:AHCL -0.69% 21 Current Accrued Expense is ₹0 Mil as of Jun. 2026. GuruFocus rates NSE:AHCL with a GF Score™ of 21/100. The stock has 6 warning signs investors should review.

Anlon Healthcare's Current Accrued Expense for the quarter that ended in Jun. 2026 was ₹0 Mil.

Anlon Healthcare Current Accrued Expense Related Terms

Anlon Healthcare Current Accrued Expense Historical Data

* Premium members only.

The historical data trend for Anlon Healthcare's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Anlon Healthcare Current Accrued Expense Chart

Anlon Healthcare Annual Data
Trend Mar22 Mar23 Mar24 Mar25 Mar26
Current Accrued Expense
0.00 0.00 0.00 0.00 0.00

Anlon Healthcare Quarterly Data
Jun24 Jun25 Sep25 Dec25 Mar26 Jun26
Current Accrued Expense Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00
NSE:AHCL
21GF Score
Anlon Healthcare Ltd NSE:AHCL
Current Accrued Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Anlon Healthcare Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

What does a Current Accrued Expense of ₹0 Mil mean?
Anlon Healthcare (NSE:AHCL) has a Current Accrued Expense of ₹0 Mil as of Jun. 2026. Current Accrued Expense records the total amount of accrued expenses. View historical data on Anlon Healthcare and its competitors.
Is Anlon Healthcare's Current Accrued Expense too high?
Anlon Healthcare's current Current Accrued Expense is ₹0 Mil. Overall, Anlon Healthcare has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Anlon Healthcare's Current Accrued Expense compare to ZTS?
Anlon Healthcare's Current Accrued Expense of ₹0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Accrued Expense for a Drug Manufacturers company?
A good Current Accrued Expense depends on the Drug Manufacturers industry context. However, Current Accrued Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Accrued Expense mean?
A high Current Accrued Expense can signal that a stock is expensive relative to its fundamentals. Current Accrued Expense records the total amount of accrued expenses. View historical data on Anlon Healthcare and its competitors. Anlon Healthcare's current Current Accrued Expense is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Anlon Healthcare stock overvalued right now?
Anlon Healthcare (NSE:AHCL) has a current Current Accrued Expense of ₹0 Mil. The current Current Accrued Expense is ₹0 Mil. Anlon Healthcare's overall GF Score™ is 21/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Accrued Expense calculated?
Current Accrued Expense is calculated from a company's financial statements. For Anlon Healthcare (NSE:AHCL), the current Current Accrued Expense is ₹0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Anlon Healthcare Business Description

Other Exchanges 544497:India
Address Kalawad Road, 101/102, Silvercoin Complex, Opposite Crystal Mall, Rajkot, GJ, IND, 360 005
Anlon Healthcare Ltd is a chemical manufacturing company engaged in manufacturing of; (i) high purity advance pharmaceutical intermediates which serves as raw material/ key starting material in the manufacturing of active pharmaceutical ingredients; and (ii) active pharmaceutical ingredients which serves as a raw material for pharmaceutical formulations in preparation of various type of Finished Dosage Formula such as tablet, capsules, ointment, syrup etc, ingredients in nutraceuticals formulations, personal care products and animal health products. Its products spans across the family of pharmaceutical intermediates, active pharmaceutical ingredients, nutraceutical APIs and ingredients for personal care and veterinary API.
21GF Score

Get the complete analysis for NSE:AHCL

Current Accrued Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹20.04
Price